REPLIGEN CORP
REPLIGEN CORP
Acción · US7599161095 · RGEN · 870980 (XNAS)
Resumen Indicadores financieros
128,30 USD
1,26 % 1,60 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 20:04

Cotizaciones actuales de REPLIGEN CORP

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
RGEN
USD
06.06.2025 20:04
128,30 USD
126,70 USD
+1,26 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 8,66 % 1,12 % -17,60 % -14,01 % -11,99 % 6,69 %

Perfil de la empresa para REPLIGEN CORP Acción

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Datos de la empresa

Nombre REPLIGEN CORP
Empresa Repligen Corporation
Símbolo RGEN
Sitio web https://www.repligen.com
Mercado principal XNAS NASDAQ
WKN 870980
ISIN US7599161095
Tipo de valor Acción
Sector Healthcare
Industria Medical - Instruments & Supplies
CEO Mr. Olivier Loeillot
Capitalización de mercado 7 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 1,8 T
Dirección Building 1, 02453 Waltham
Fecha de OPV 1986-04-29

Símbolos de cotización

Nombre Símbolo
Frankfurt RGN.F
NASDAQ RGEN

Otras acciones

Los inversores que tienen REPLIGEN CORP también tienen las siguientes acciones en su cartera:
ACELRX PHARMACEUTICALS INC
ACELRX PHARMACEUTICALS INC Acción
AMGEN INC
AMGEN INC Acción
APPLE INC
APPLE INC Acción
AUTODESK INC
AUTODESK INC Acción
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Acción
CISCO SYSTEMS INC
CISCO SYSTEMS INC Acción
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Acción
FASTENAL CO
FASTENAL CO Acción
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Acción
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Acción
KLA CORP
KLA CORP Acción
NOKIA CORP
NOKIA CORP Acción
Themes Cloud Computing ETF
Themes Cloud Computing ETF ETF
VONTOBEL-US EQUITY B-DL
VONTOBEL-US EQUITY B-DL Fondo
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025